biote Corp. SEC filings BTMD
biote Corp. has 411 filings in SEC EDGAR's recent list, going back to Aug 6, 2020. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFR14A | Filing | May 5, 2025 | — |
| EFFECT | Filing | Apr 11, 2025 | — |
| EFFECT | Filing | Apr 2, 2024 | — |
| EFFECT | Filing | Apr 2, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2023 | — |
| CORRESP | Letter to the SEC | Oct 5, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2023 | — |
| 25-NSE | Delisting notice | Jul 7, 2023 | — |
| SC TO-I/A | Filing | Jun 9, 2023 | — |
| 425 | Filing | Jun 9, 2023 | — |
| EFFECT | Filing | Jun 7, 2023 | — |
| CORRESP | Letter to the SEC | Jun 6, 2023 | — |
| CORRESP | Letter to the SEC | May 23, 2023 | — |
| UPLOAD | Letter from the SEC | May 17, 2023 | — |
| DEL AM | Filing | May 15, 2023 | — |
| 425 | Filing | May 10, 2023 | — |
| SC TO-I | Filing | May 9, 2023 | — |
| EFFECT | Filing | Apr 11, 2023 | — |
| EFFECT | Filing | Apr 11, 2023 | — |
| EFFECT | Filing | Jan 4, 2023 | — |
| CORRESP | Letter to the SEC | Jan 3, 2023 | — |
| CORRESP | Letter to the SEC | Jan 3, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2022 | — |
| CERT | Filing | Aug 26, 2022 | — |
| 8-A12B | Filing | Aug 25, 2022 | — |
| EFFECT | Filing | Aug 5, 2022 | — |
| CORRESP | Letter to the SEC | Aug 3, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2022 | — |
| EFFECT | Filing | Jul 19, 2022 | — |
| CORRESP | Letter to the SEC | Jul 15, 2022 | — |
| CORRESP | Letter to the SEC | Jul 11, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2022 | — |
| CORRESP | Letter to the SEC | Jun 28, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2022 | — |
| 25-NSE | Delisting notice | May 26, 2022 | — |
| NT 10-Q | Filing | May 16, 2022 | Mar 31, 2022 |
| UPLOAD | Letter from the SEC | May 4, 2022 | — |
| CORRESP | Letter to the SEC | Apr 27, 2022 | — |
| PRER14A | Filing | Apr 27, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2022 | — |
| CORRESP | Letter to the SEC | Apr 8, 2022 | — |
| PRER14A | Filing | Apr 8, 2022 | — |
| NT 10-K | Filing | Apr 1, 2022 | Dec 31, 2021 |
| UPLOAD | Letter from the SEC | Mar 16, 2022 | — |
| NT 10-Q | Filing | Nov 15, 2021 | Sep 30, 2021 |
| NT 10-Q | Filing | Aug 16, 2021 | Jun 30, 2021 |
| NT 10-Q | Filing | May 17, 2021 | Mar 31, 2021 |
| EFFECT | Filing | Mar 1, 2021 | — |
| CERT | Filing | Mar 1, 2021 | — |
| 8-A12B | Filing | Feb 26, 2021 | — |
| CORRESP | Letter to the SEC | Feb 25, 2021 | — |
| CORRESP | Letter to the SEC | Feb 25, 2021 | — |
| CORRESP | Letter to the SEC | Feb 11, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2021 | — |
| DRS/A | Filing | Jan 25, 2021 | — |
| DRS | Filing | Aug 6, 2020 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- BTMD (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Irving, TX
- SEC filer status
- Accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1819253
- Former names
- Haymaker Acquisition Corp. III (until May 25, 2022)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.